Ansøgeren skulle gennemgå sikkerheden og virkningen af cefuroximaxetil ved ukompliceret gonorré og drage konklusioner om benefit/ risk- forholdet for denne ansøgte indikation.
The applicant had to address the safety and efficacy of cefuroximaxetil in uncomplicated gonorrhoea and to conclude on the risk-benefit balance for this sought indication.